Interim report January – March 2021 – Correction
Correction – Auditor’s review of the interim report on page 8. Curasight A/S (“Curasight” or “the Company”) hereby publishes the interim report for the period January 1 – March 31, 2021. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.Curasight’s CEO Ulrich Krasilnikoff comments: “Curasight accomplished essential milestones during the first quarter by being granted two patents, one in the US and one in Canada. Results from a phase II study in prostate cancer patients conducted by researchers at